Systemic Management in Extremely Preterm and Extremely Low Birth Weight Infants
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Peking University
- Principal Investigator
- Qi FengPeking University First Hospital
- Intervention
- no interventions(other)
- Enrollment
- 1200 enrolled
- Eligibility
- All sexes
- Timeline
- 2019 – 2020
Study locations (1)
- Qi Feng, Beijing, Beijing Municipality, China
Collaborators
Peking University First Hospital · Peking University People's Hospital · Peking University Third Hospital · Tianjin Central Hospital of Gynecology Obstetrics · Peking Union Medical College Hospital · Beijing Children's Hospital · Beijing Friendship Hospital · Shanxi Provincial Maternity and Children's Hospital · The Second Hospital of Hebei Medical University · Handan Central Hospital · Xingtai People's Hospital · Tianjin Medical University General Hospital · The Affiliated Hospital of Inner Mongolia Medical University · Children's Hospital of Hebei Province · Tianjin First Central Hospital · Chifeng Municipal Hospital · Tianjin Medical University Second Hospital · PLA Rocket Force Characteristic Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06082414 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGPHASE1NCT06589245Inhaled Ciclesonide Study in Preterm InfantsVenkatesh Sampath